EP2068938
Hámörkun meðhöndlunarinnar á Fíladelfíu-jákvæðu hvítblæði með ABL týrósínkínasahindra imatíníbi.
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
20.9.2007EP published:
19.1.2011EP application number:
07842842.2
EP translation filed:
7.4.2011Grant published:
15.5.2011EPO information:
European Patent Register
Max expiry date:
19.9.2027Expiry date:
19.9.2014
Title:
OPTIMIZATION OF THE TREATMENT OF PHILADELPHIA-POSITIVE LEUKEMIA WITH ABL TYROSINE KINASE INHIBITOR IMATINIB
Timeline
Today
20.9.2007EP application
19.1.2011EP Publication
7.4.2011Translation submitted
15.5.2011Registration published
19.9.2014Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, CH-4056, Basel, CH
Inventor
Name:
GATHMANN, InsaAddress:
Basel, CH
Name:
MAHON, Francois-XavierAddress:
Bordeaux, FR
Name:
MOLIMARD, MathieuAddress:
Bordeaux, FR
Name:
PICARD, StéphaneAddress:
Bordeaux, FR
Name:
WANG, YanfengAddress:
Florham Park, New Jersey, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
826622 PDate:
22.9.2006Country:
US
Number:
828278 PDate:
5.10.2006Country:
US
Classification
Categories:
A61K 49/00, A61P 35/02, A61K 31/00, A61K 31/506
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 10.8.2011
Expires: 19.9.2012
Payer: Sigurjónsson & Thor ehf.
Number: 6
Paid: 8.8.2012
Expires: 19.9.2013
Payer: Sigurjónsson & Thor ehf.
Number: 7
Paid: 8.8.2013
Expires: 19.9.2014
Payer: Árnason Faktor